Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
VOR
VOR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VOR News
Vor Biopharma Reports Significant Increase in Q1 Net Loss
May 13 2026
seekingalpha
Vor Bio Reports Q1 2026 Financial Results and Updates on Telitacicept Trials
May 13 2026
Newsfilter
Vor Biopharma Reports Q4 2025 Net Income Surge
Mar 30 2026
seekingalpha
Latest Wall Street Rating Updates
Mar 30 2026
CNBC
RPT-VOR BIOPHARMA REPORTS Q4 NET INCOME OF USD 1,722.8 MILLION, SURPASSING IBES ESTIMATE OF USD -28.9 MILLION
Mar 30 2026
moomoo
VOR Biopharma Inc: Jefferies Begins Coverage with a Buy Rating and Sets Target Price at $50
Mar 30 2026
moomoo
VOR Biopharma Stock Increases by 1.5% Following $75 Million Private Placement
Mar 27 2026
moomoo
Vor Bio Secures $75M in Private Placement Financing
Mar 27 2026
seekingalpha
Vor Bio Secures $75 Million in Private Placement Financing
Mar 27 2026
Newsfilter
Vor Biopharma Appoints Two New Board Members to Support $150M PIPE Financing
Dec 23 2025
Globenewswire
Vor Bio Secures $150 Million in Private Placement at $10.81 per Share
Dec 15 2025
Newsfilter
J.P. Morgan Initiates Coverage on Lead Asset with Overweight Rating, Boosting Bio Shares
Dec 09 2025
SeekingAlpha
Vor Biopharma (VOR) Receives Upgrade to Buy: Key Information You Need to Know
Nov 25 2025
NASDAQ.COM
HC Wainwright & Co. Upholds Buy Rating for Vor Biopharma (VOR)
Nov 15 2025
NASDAQ.COM
HC Wainwright & Co. Reaffirms Buy Rating for Vor Biopharma, Adjusts Price Target to $32
Nov 14 2025
Benzinga
Dow Rises Over 300 Points; Energy Vault Holdings Stock Soars
Nov 11 2025
Benzinga
Show More News
